Published in Diabetes Care on June 05, 2008
Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov (2009) 1.45
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study. Diabetes Obes Metab (2015) 0.91
The Effects of Leucine, Zinc, and Chromium Supplements on Inflammatory Events of the Respiratory System in Type 2 Diabetic Rats. PLoS One (2015) 0.75
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med (1995) 3.95
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med (2005) 3.92
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir (1982) 2.77
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea. Diabetes Care (2006) 2.74
The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study. Diabetes Care (2005) 2.18
Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care (2004) 2.09
Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis (1985) 1.64
Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health (1999) 1.61
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin. Diabetes Care (2006) 1.46
Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration (1999) 1.40
Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care (2004) 1.38
Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. Chest (2007) 1.26
Instrument accuracy and reproducibility in measurements of pulmonary function. Chest (2007) 1.17
Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol (2003) 1.02
Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care (2007) 1.00
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care (2005) 0.97
Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. J Clin Endocrinol Metab (2005) 0.96
Lung function changes related to diabetes mellitus. Diabetes Technol Ther (2007) 0.89
Standardization of the single-breath diffusing capacity in a multicenter clinical trial. Chest (2007) 0.88
Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Int J Clin Pract (2007) 0.86
Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy. Am J Respir Crit Care Med (2006) 0.85
Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch (1995) 0.84
Finding signals amidst the noise in pulmonary function testing. Chest (2007) 0.78
Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med (2007) 6.79
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet (2010) 5.45
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med (2005) 3.92
How do we define cure of diabetes? Diabetes Care (2009) 3.59
Is it time to change the way we report and discuss weight loss? Obesity (Silver Spring) (2009) 3.57
Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes (2009) 3.17
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care (2013) 2.89
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet (2007) 2.65
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med (2007) 2.41
Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care (2012) 2.21
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system. Rev Assoc Med Bras (2012) 2.15
Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care (2006) 2.04
Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab (2013) 1.79
Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest (2012) 1.78
Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism (2007) 1.73
Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite (2010) 1.64
The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2005) 1.62
Familial history of type 2 diabetes in patients from Southern Brazil and its influence on the clinical characteristics of this disease. Arq Bras Endocrinol Metabol (2006) 1.60
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes Care (2013) 1.56
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial. BMC Med (2013) 1.55
Does body mass index adequately convey a patient's mortality risk? JAMA (2013) 1.54
Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr (2010) 1.52
Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr (2006) 1.51
Glycemic control and cardiovascular disease--should we reassess clinical goals? N Engl J Med (2005) 1.49
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. Curr Med Res Opin (2013) 1.46
Impact of white-coat hypertension on microvascular complications in type 2 diabetes. Diabetes Care (2008) 1.45
Which patients with diabetes should undergo ambulatory blood pressure monitoring? J Hypertens (2011) 1.45
Should troponin and creatinine kinase be routinely measured after vascular surgery? Vasc Med (2007) 1.44
Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with type 2 diabetes mellitus: a prospective study. Arq Bras Endocrinol Metabol (2006) 1.43
Glycemic targets and cardiovascular disease. N Engl J Med (2008) 1.42
A natural history of botanical therapeutics. Metabolism (2008) 1.41
The integral role of clinical research in clinical care. N Engl J Med (2003) 1.39
Microvascular complications and cardiac autonomic dysfunction in patients with diabetes mellitus type 1. Arq Bras Cardiol (2011) 1.39
Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism (2008) 1.37
Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes (2008) 1.35
Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab (2006) 1.34
Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes (2008) 1.31
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism (2008) 1.27
Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology (2006) 1.26
Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study. Diabetes Care (2008) 1.26
Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care (2011) 1.23
Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care (2013) 1.21
An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice. J Nutr Biochem (2010) 1.18
Complications of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 1.18
Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome. J Clin Endocrinol Metab (2011) 1.18
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. Am J Physiol Endocrinol Metab (2007) 1.15
Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi transporter) reduces physical endurance and metabolic efficiency in mice. J Biol Chem (2011) 1.11
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. Nicotine Tob Res (2011) 1.10
Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. Int J Pharm (2008) 1.09
Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures. Mol Cell Endocrinol (2006) 1.08
Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis (2002) 1.08
Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care (2013) 1.07
Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther (2002) 1.07
Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care (2007) 1.07
Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring) (2011) 1.06
Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension. J Am Geriatr Soc (2014) 1.05
Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Diabetes Care (2007) 1.04
Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism (2013) 1.03
Modulation of skeletal muscle insulin signaling with chronic caloric restriction in cynomolgus monkeys. Diabetes (2009) 1.03
Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells. Diabetes (2012) 1.03
Basal insulin or premix analogue therapy in type 2 diabetes patients. Eur J Intern Med (2007) 1.03
A prospective study of abdominal obesity and coronary artery calcium progression in older adults. J Clin Endocrinol Metab (2009) 1.02
Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr Diab Rep (2010) 1.01
Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism (2008) 0.99
Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism (2007) 0.99
Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci Med Sci (2002) 0.99
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care (2005) 0.97
Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes patients with macroalbuminuria. Am J Clin Nutr (2006) 0.97
Diabetes Care: “state of the union”. Diabetes Care (2013) 0.97
Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2008) 0.97
Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem (2011) 0.96
Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes. Br J Med Med Res (2012) 0.95
20-Hydroxyecdysone decreases weight and hyperglycemia in a diet-induced obesity mice model. Am J Physiol Endocrinol Metab (2009) 0.95
RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. J Clin Endocrinol Metab (2003) 0.94
Evaluation of botanicals for improving human health. Am J Clin Nutr (2008) 0.94
The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes (2005) 0.94
Disrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associated wasting. J Infect Dis (2011) 0.94
Charcoal hemoperfusion in the treatment of levothyroxine intoxication. Thyroid (2010) 0.93
Progress to date for Diabetes Care: going mobile and putting information at your fingertips! Diabetes Care (2012) 0.93
HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care (2013) 0.93
The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study. J Pediatr (2010) 0.92
Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes. Diabetes Care (2005) 0.92
Steps toward the meaningful translation of prevention strategies for type 2 diabetes. Diabetes Care (2012) 0.92
Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open (2013) 0.92
Diastolic dysfunction and mortality in diabetic patients on hemodialysis: a 4.25-year controlled prospective study. J Diabetes Complications (2005) 0.91
The importance of waist circumference and BMI for mortality risk in diabetic adults. Diabetes Care (2013) 0.91
The UCP1 -3826A/G polymorphism is associated with diabetic retinopathy and increased UCP1 and MnSOD2 gene expression in human retina. Invest Ophthalmol Vis Sci (2012) 0.91
Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol (2005) 0.90
The “evidence” is in! It does get better! Diabetes Care (2015) 0.89
Adipocyte iron regulates leptin and food intake. J Clin Invest (2015) 0.89
The contribution of race and diabetes status to metabolic flexibility in humans. Metabolism (2010) 0.88
Regulation of insulin action by an extract of Artemisia dracunculus L. in primary human skeletal muscle culture: a proteomics approach. Phytother Res (2010) 0.88
Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetol Metab Syndr (2010) 0.88
Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans. Diabetes (2012) 0.88
Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Clin Endocrinol (Oxf) (2009) 0.87
Intensive glycemic control and cardiovascular disease observations from the ACCORD study: now what can a clinician possibly think? Diabetes (2008) 0.87
Family support in assertive community treatment: an analysis of client outcomes. Community Ment Health J (2011) 0.87